Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date24 Mar 2003 |
100 Clinical Results associated with Shenyang Xinma Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Shenyang Xinma Pharmaceutical Co., Ltd.
100 Deals associated with Shenyang Xinma Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Shenyang Xinma Pharmaceutical Co., Ltd.